Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 3.270
+0.010 (0.31%)
Aug 12, 2026, 4:11 PM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 264.86 million as of August 12, 2026. Its market cap has decreased by -34.80% in one year.
Market Cap
264.86M
Enterprise Value
239.88M
Revenue
407.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.27
ChartMarket Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 264.86M, an increase of 480.08%. That is a compound annual growth rate of 9.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 264.86M | 4.82% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 63.31B |
| Sigma Healthcare | 34.28B |
| Pro Medicus | 18.40B |
| Sonic Healthcare | 10.99B |
| Starpharma Holdings | 332.71M |
| Healius | 304.99M |
| Monash IVF Group | 266.90M |
| Paragon Care | 215.19M |